Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine – Part 2: Immunohistochemistry Test Performance Characteristics. Issue 2 (February 2017)

• Record Type: Journal Article
• Authors: Torlakovic, Emina E.; Cheung, Carol C.; D'Arrigo, Corrado; Dietel, Manfred; Francis, Glenn D.; Gilks, C. Blake; Hall, Jacqueline A.; Hornick, Jason L.; Ibrahim, Merdol; Marchetti, Antonio; Miller, Keith; van Krieken, J. Han; Nielsen, Soren; Swanson, Paul E.; Vyberg, Mogens; Zhou, Xiaoge; Taylor, Clive R.
• Is Part Of: Applied immunohistochemistry & molecular morphology. Volume 25:Issue 2(2017)
• Publication Date: 2017-02
• Subjects: biomarkers -- quality assurance -- quality control -- validation -- immunohistochemistry -- test performance characteristics; Diagnostic immunohistochemistry -- Periodicals; Immunohistochemistry -- Periodicals; Cells -- Morphology -- Periodicals; Molecular diagnosis -- Periodicals; 616.079
• DOI: 10.1097/PAI.0000000000000444
• Languages: English
• ISSNs: 1541-2016

Abstract

Abstract : All laboratory tests have test performance characteristics (TPCs), whether or not they are explicitly known to the laboratorian or the pathologist. TPCs are thus also an integral characteristic of immunohistochemistry (IHC) tests and other in situ, cell-based molecular assays such as DNA or RNA in situ hybridization or aptamer-based testing. Because of their descriptive, in situ, cell-based nature, IHC tests have a limited repertoire of appropriate TPCs. Although only a few TPCs are relevant to IHC, proper selection of informative TPCs is nonetheless essential for the development of and adherence to appropriate quality assurance measures in the IHC laboratory. This paper describes the TPCs that are relevant to IHC testing and emphasizes the role of TPCs in the validation of IHC tests. This is part 2 of the 4-part series "Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine."